This project team will create a White Paper with recommendations for analyses and displays associated with hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.

Project Leads:

Melvin Munsaka - melvin.munsaka@abbvie.com

Terry Walsh - terry.walsh@astellas.com